Oligomerization conditions Mdm2-mediated efficient p53 polyubiquitylation but not its proteasomal degradation

被引:13
|
作者
Hjerpe, Roland [1 ]
Aillet, Fabienne [1 ]
Lopitz-Otsoa, Fernando [1 ]
Lang, Valerie [1 ]
Torres-Ramos, Monica [1 ]
Farras, Rosa [3 ]
Hay, Ronald T. [4 ]
Rodriguez, Manuel S. [1 ,2 ]
机构
[1] CIC bioGUNE, Prote Unit, CIBERehd, Derio 48160, Bizkaia, Spain
[2] Univ Basque Country, Dept Biochem, Leioa 48940, Bizkaia, Spain
[3] Ctr Invest Principe Felipe, Valencia 46013, Spain
[4] Univ Dundee, Sch Life Sci, Interdisciplinary Res Ctr, Dundee DD1 5EH, Scotland
关键词
p53; Polyubiquitylation; Degradation; Mdm2; Proteasome; TERMINAL DOMAIN; TRANSCRIPTIONAL ACTIVITY; PROTEIN-DEGRADATION; ACTIVATE P53; IN-VIVO; UBIQUITINATION; MDM2; MULTIPLE; IDENTIFICATION; MUTATIONS;
D O I
10.1016/j.biocel.2010.01.010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In normal cells p53 is maintained at low level through the action of the ubiquitin-proteasome system. As a consequence of p53 transcriptional activity, various regulators of this tumor suppressor are produced, forming a negative feedback loop tightly controlling p53 stability. One of the most prominent is the ubiquitin-ligase Mdm2. Here, we have used a transfer of signals strategy to study the p53 degradation process promoted by Mdm2 in the absence of p53 transcriptional activity. Our results show that in a p53 null background, transcriptionally silent p53-fusions require multiple N- and C-terminal signals to be optimally targeted to proteasomal degradation. As for WT p53, p53-fusions able to form tetramers are polyubiquitylated and optimally degraded by the proteasome. However, p53 molecules unable to oligomerize, show Mdm2-mediated polyubiquitylation deficiency but are still targeted to proteasome degradation in vitro and ex vivo. In the presence of Mdm2, nuclear shuttling of p53 monomeric fusions favours proteasome-dependent degradability but not its polyubiquitylation. In vitro, 265 proteasome fails to drive degradation of OD mutants in the presence of Mdm2, suggesting the contribution of additional cellular factors in this process. All together, our results indicate that Mdm2-mediated proteasome-dependent degradation of polyubiquitylation deficient p53 monomers is mechanistically possible, taking alternative pathways to better achieve their proteolysis. These results support the existence of additional levels to regulate p53 stability and activity acting on individual subunits of the functional tetramer. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:725 / 735
页数:11
相关论文
共 50 条
  • [31] Ribosomal protein S7 as a novel modulator of p53–MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function
    D Chen
    Z Zhang
    M Li
    W Wang
    Y Li
    E R Rayburn
    D L Hill
    H Wang
    R Zhang
    Oncogene, 2007, 26 : 5029 - 5037
  • [32] AKT-dependent phosphorylation of Niban regulates nucleophosmin- and MDM2-mediated p53 stability and cell apoptosis
    Ji, Haitao
    Ding, Zhiyong
    Hawke, David
    Xing, Dongming
    Jiang, Bing-Hua
    Mills, Gordon B.
    Lu, Zhimin
    EMBO REPORTS, 2012, 13 (06) : 554 - 560
  • [33] Epigallocatechin gallate promotes p53 accumulation and activity via the inhibition of MDM2-mediated p53 ubiquitination in human lung cancer cells
    Jin, Longyu
    Li, Cui
    Xu, Yan
    Wang, Li
    Liu, Jianxin
    Wang, Dianjun
    Hong, Cao
    Jiang, Zhibing
    Ma, Yuchao
    Chen, Qian
    Yu, Fenglei
    ONCOLOGY REPORTS, 2013, 29 (05) : 1983 - 1990
  • [34] p53 proteasomal degradation - Poly-ubiquitination is not the whole story
    Asher, G
    Shaul, Y
    CELL CYCLE, 2005, 4 (08) : 1015 - 1018
  • [35] Modulation of p53 degradation via MDM2-mediated ubiquitylation and the ubiquitin-proteasome system during reperfusion after stroke: role of oxidative stress
    Saito, A
    Hayashi, T
    Okuno, S
    Nishi, T
    Chan, PH
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2005, 25 (02) : 267 - 280
  • [36] LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation
    Zeng, Kaixuan
    Chen, Xiaoxiang
    Hu, Xiuxiu
    Liu, Xiangxiang
    Xu, Tao
    Sun, Huiling
    Pan, Yuqin
    He, Bangshun
    Wang, Shukui
    ONCOGENE, 2018, 37 (41) : 5534 - 5551
  • [37] Mdm2 Splice isoforms regulate the p53/Mdm2/Mdm4 regulatory circuit via RING domain-mediated ubiquitination of p53 and Mdm4
    Fan, Chuandong
    Wang, Xinjiang
    CELL CYCLE, 2017, 16 (07) : 660 - 664
  • [38] Anoikis triggers Mdm2-dependent p53 degradation
    Ghosh, Abhijit
    Chen, Tina Chunyuan
    Kapila, Yvonne L.
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2010, 343 (1-2) : 201 - 209
  • [39] Targeting MDM2-mediated suppression of p53 with idasanutlin: a promising therapeutic approach for acute lymphoblastic leukemia
    Gungordu, Seyda
    Aptullahoglu, Erhan
    INVESTIGATIONAL NEW DRUGS, 2024, 42 (06) : 603 - 611
  • [40] cIAP2 represses IKKα/β-mediated activation of MDM2 to prevent p53 degradation
    Lau, Rosanna
    Niu, Min Ying
    Pratt, M. A. Christine
    CELL CYCLE, 2012, 11 (21) : 4009 - 4019